Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [2]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952531 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Glucose-6-Phosphate Isomerase (GPI) (AA 452-481), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- C-Term, AA 452-481
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references New genetic associations detected in a host response study to hepatitis B vaccine.
PI 3-kinase/Akt and STAT3 are required for the prevention of TGF-beta-induced Hep3B cell apoptosis by autocrine motility factor/phosphoglucose isomerase.
Phosphoglucose isomerase enhances colorectal cancer metastasis.
Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8.
Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer.
Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation.
Precursors of the pyrimidine and thiazole rings of thiamine.
Davila S, Froeling FE, Tan A, Bonnard C, Boland GJ, Snippe H, Hibberd ML, Seielstad M
Genes and immunity 2010 Apr;11(3):232-8
Genes and immunity 2010 Apr;11(3):232-8
PI 3-kinase/Akt and STAT3 are required for the prevention of TGF-beta-induced Hep3B cell apoptosis by autocrine motility factor/phosphoglucose isomerase.
Shih WL, Liao MH, Lin PY, Chang CI, Cheng HL, Yu FL, Lee JW
Cancer letters 2010 Apr 28;290(2):223-37
Cancer letters 2010 Apr 28;290(2):223-37
Phosphoglucose isomerase enhances colorectal cancer metastasis.
Tsutsumi S, Fukasawa T, Yamauchi H, Kato T, Kigure W, Morita H, Asao T, Kuwano H
International journal of oncology 2009 Nov;35(5):1117-21
International journal of oncology 2009 Nov;35(5):1117-21
Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8.
Araki K, Shimura T, Yajima T, Tsutsumi S, Suzuki H, Okada K, Kobayashi T, Raz A, Kuwano H
The Journal of biological chemistry 2009 Nov 20;284(47):32305-11
The Journal of biological chemistry 2009 Nov 20;284(47):32305-11
Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer.
Funasaka T, Hogan V, Raz A
Cancer research 2009 Jul 1;69(13):5349-56
Cancer research 2009 Jul 1;69(13):5349-56
Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation.
Yanagawa T, Funasaka T, Tsutsumi S, Raz T, Tanaka N, Raz A
The Journal of biological chemistry 2005 Mar 18;280(11):10419-26
The Journal of biological chemistry 2005 Mar 18;280(11):10419-26
Precursors of the pyrimidine and thiazole rings of thiamine.
Tomlinson RV, Kuhlman DP, Torrence PF, Tieckelmann H
Biochimica et biophysica acta 1967 Oct 9;148(1):1-10
Biochimica et biophysica acta 1967 Oct 9;148(1):1-10
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS
